Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?23.48

?23.48

 
WKN: A3D38K / Symbol: FWBI / Name: First Wave BioPharma / Stock / Pharmaceuticals / Micro Cap /
Latest predictions
€36.68
03.01.24
-
buy
€10.29
19.09.23
0.00%
buy
Your prediction

First Wave BioPharma Inc. Stock

With 0 Sell predictions and 2 Buy predictions the community sentiment towards the First Wave BioPharma Inc. stock is not clear.
Based on the current price of 3.95 € the target price of 23 € shows a potential of 482.57% for First Wave BioPharma Inc. which would more than double the current price.
For the coming years our community has positive and negative things to say abot the First Wave BioPharma Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.

Pros and Cons of First Wave BioPharma Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 36.676
Change
Ends at 03.01.25

First Wave BioPharma, Inc. (NASDAQ: FWBI) had its price target raised by analysts at Roth Mkm from $11.00 to $40.00. They now have a "buy" rating on the stock.
Ratings data for FWBI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.00%
Target price 10.293
Change
Ends at 19.09.24

First Wave BioPharma, Inc. (NASDAQ: FWBI) had its "buy" rating re-affirmed by analysts at Roth Mkm. They now have a $11.00 price target on the stock.
Ratings data for FWBI provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 677.78%
Target price 17.010
Change
Ends at 09.03.24

First Wave BioPharma, Inc. (NASDAQ: FWBI) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock.
Ratings data for FWBI provided by MarketBeat
Show more